EFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSIS

Basit Öğe Kaydı
dc.contributor.authorSoyer, N.
dc.contributor.authorTurgut, M.
dc.contributor.authorHaznedaroglu, I.
dc.contributor.authorYilmaz, F.
dc.contributor.authorAydogdu, I.
dc.contributor.authorPir, A.
dc.contributor.authorKarakus, V.
dc.date.accessioned2024-09-18T21:01:46Z
dc.date.available2024-09-18T21:01:46Z
dc.date.issued2017
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description8th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 18-21, 2017 -- Istanbul, TURKEYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS19en_US
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.startpageS19en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12999
dc.identifier.volume61en_US
dc.identifier.wosWOS:000416742600048en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofLeukemia Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSISen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu